Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osveral versus Exjade in beta-thalassemia major
IRCT20090813002342N9Phase 4Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of deferasirox in beta thalassemia (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Mean change in serum ferritin concentration. Started Aug 2015; status: completed.
02
Drugs
deferasirox
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on IRCT20090813002342N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090813002342N9.